DYNLL2 Activators
DYNLL2 Activators are a diverse group of chemical compounds that enhance the functional activity of DYNLL2 through specific and indirect modulation of cellular signaling pathways and protein interactions. Forskolin, by increasing intracellular cAMP, indirectly augments DYNLL2's involvement in cellular transport processes through PKA activation andsubsequent phosphorylation events. Similarly, PMA, through PKC activation, may enhance the motor activity of DYNLL2 by influencing phosphorylation states of proteins within the dynein complex. Lithium chloride's inhibition of GSK-3 and Okadaic acid's inhibition of protein phosphatases could lead to an enhanced stability and function of DYNLL2-associated cargo proteins. This stabilization may, in turn, promote the efficiency of DYNLL2-mediated transport. Calyculin A shares a similar mechanism with okadaic acid, potentially amplifying the function of DYNLL2 by altering phosphorylation patterns of associated proteins. EGCG, with its kinase inhibitory properties, could indirectly upregulate DYNLL2's activity by impacting signaling cascades relevant to its function.
Ionomycin's elevation of intracellular calcium levels might trigger calcium-dependent kinase activity, which could indirectly enhance DYNLL2's function in intracellular transport. Likewise, sphingosine-1-phosphate may activate receptors that initiate signaling events, ultimately potentiating DYNLL2's interaction with other components of the dynein complex, thus improving its transport capabilities. The use of 8-Bromo-cAMP, a cAMP analog, activates PKA and could similarly influence the activity of DYNLL2 through phosphorylation of associated proteins. Thapsigargin, by increasing cytosolic calcium, might indirectly modulate the function of DYNLL2 through the activation of calcium-dependent signaling pathways. Tetrodotoxin, while primarily known as a sodium channel blocker, could alter intracellular dynamics and potentially affect the function of DYNLL2 indirectly. Lastly, paclitaxel stabilizes microtubules, which may enhance the microtubule-based transport functions of DYNLL2, potentiating its role in intracellular trafficking.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, increasing intracellular cAMP levels. Elevated cAMP activates PKA, which can phosphorylate downstream proteins that may interact with DYNLL2, potentially altering its activity by changing its protein interactions. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which could phosphorylate substrates that modulate the motor activity of DYNLL2, thereby indirectly enhancing its function in cargo transport within cells. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride inhibits glycogen synthase kinase-3 (GSK-3). Inhibition of GSK-3 could stabilize proteins that associate with DYNLL2, thus potentially enhancing DYNLL2's stabilization of its binding partners. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases 1 and 2A, leading to increased phosphorylation levels within the cell. This could enhance the activity of proteins that interact with DYNLL2 and modulate its function. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Similar to okadaic acid, calyculin A inhibits protein phosphatases, leading to a state of hyperphosphorylation that may indirectly enhance the function of DYNLL2 by modifying its interaction with partner proteins. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin gallate (EGCG) has been shown to have kinase inhibitory activity. This could lead to alteration in signaling pathways that modulate the activity of proteins interacting with DYNLL2, potentially enhancing its functional activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that raises intracellular calcium levels, which could activate calcium-dependent kinases and phosphatases that modulate the activity of DYNLL2-associated proteins, thereby influencing DYNLL2 activity. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate activates sphingosine-1-phosphate receptors, initiating signaling cascades that might enhance the interaction of DYNLL2 with other dynein complex components, potentially increasing its transport function. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP is a cell-permeable cAMP analog that activates PKA. PKA may phosphorylate proteins that regulate the activity of DYNLL2, thus enhancing its function in intracellular processes such as organelle transport. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is an inhibitor of the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to increased cytosolic calcium, which could activate pathways that modulate the activity of proteins associated with DYNLL2. | ||||||